Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
SYNTEX' NAPROSYN/ANAPROX COMBINED SALES IN U.S. APPROACH $90 MIL. IN SECOND QUARTER OF FY 1986; FIRST HALF NAPROXEN SALES TOP $250 MIL. WORLDWIDE
Mar 03 1986
•
By
The Pink Sheet
More from Archive
More from Pink Sheet